Wall Street Journal August 2, 2023
AI enables researchers to weave ‘synthetic data’ from sets of patient data. But CIOs question whether the generated data sufficiently captures the medical variables useful in research
Healthcare companies have been mesmerized by the possibilities of “synthetic data”—data built out by applying artificial intelligence algorithms to real data sets. But ongoing technology challenges continue to limit widespread industry adoption, with many companies holding back on using it.
For years, drug and health researchers have been experimenting with the technology, which enables them to more freely analyze, for example, the impact of a drug on a given subpopulation, without the typical privacy and regulatory hurdles. A 2021 Gartner study estimated that by next year, 60% of the data used broadly...
Today's Sponsors
Today's Sponsor